Login / Signup

Home Haemoglobin Monitoring for the Titration of Erythropoietin-Stimulating Agents in Chronic Kidney Disease: A Pragmatic Pilot Trial.

Richard BodingtonMadeline LokSunil Bhandari
Published in: Diagnostics (Basel, Switzerland) (2024)
One year of home self-testing with Luma yielded comparable device utility to other POCT haematology analysers derived via HCP testing. Innovative pilot trials such as this form the basis for new empowering and home-based models of care required and desired by patients and HCPs.
Keyphrases
  • healthcare
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • study protocol
  • palliative care
  • quality improvement
  • clinical trial
  • recombinant human